13F Filings History of BARD ASSOCIATES INC

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$376,816,195
Signature - Title
Molly Wheeler - Compliance Consultant
Location
Chicago, IL
Summary
This page shows a list of all the recent 13F filings made by BARD ASSOCIATES INC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BARD ASSOCIATES INC reported 160 stock holdings with total value $376,816,195 as of Q3 2025. Top holdings included PFF, FFC, BIZD, ENSG, and COHR.

Notify me when BARD ASSOCIATES INC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 160 $376,816,195 +$64,769,135 -$49,281,214 +$15,487,921 PFF, FFC, BIZD, ENSG, COHR 13F-HR 14 Nov 2025, 13:50
Q2 2025 173 $311,113,011 +$44,928,359 -$28,033,350 +$16,895,009 ENSG, BIZD, WLDN, COHR, FFC 13F-HR 05 Aug 2025, 10:31
Q1 2025 179 $268,116,392 +$8,314,104 -$11,069,297 -$2,755,193 ENSG, TPZ, COHR, BKTI, WLDN 13F-HR 09 May 2025, 18:35
Q4 2024 180 $294,287,429 +$19,732,906 -$31,318,725 -$11,585,819 ENSG, TPZ, COHR, AMPG, FIP 13F-HR 06 Feb 2025, 12:27
Q3 2024 177 $293,390,507 +$11,003,792 -$6,185,352 +$4,818,440 ENSG, FIP, COHR, MAMA, WLDN 13F-HR 06 Nov 2024, 15:24
Q2 2024 172 $259,436,096 +$5,433,659 -$13,638,538 -$8,204,879 ENSG, FIP, COHR, MAMA, AROC 13F-HR 12 Aug 2024, 12:00
Q1 2024 176 $278,129,060 +$12,827,709 -$17,321,443 -$4,493,734 ENSG, FIP, COHR, USPH, ACU 13F-HR 13 May 2024, 10:53
Q4 2023 173 $263,339,497 +$8,989,385 -$17,547,243 -$8,557,858 ENSG, SMID, CELH, FIP, MAMA 13F-HR 13 Feb 2024, 09:56
Q3 2023 187 $241,548,676 +$7,798,318 -$2,839,649 +$4,958,669 ENSG, CELH, USAC, MAMA, FIP 13F-HR 13 Nov 2023, 10:29
Q2 2023 185 $255,803,948 +$13,455,564 -$12,289,863 +$1,165,701 ENSG, USPH, COHR, FIP, CELH 13F-HR 11 Aug 2023, 11:55
Q1 2023 190 $242,041,048 +$10,858,432 -$9,221,871 +$1,636,561 ENSG, CELH, USPH, USAC, FIP 13F-HR 12 May 2023, 10:09
Q4 2022 194 $232,276,046 +$13,564,168 -$8,066,399 +$5,497,769 ENSG, CELH, USAC, SMID, FIP 13F-HR 10 Feb 2023, 10:35
Q3 2022 187 $221,598,000 +$18,834,603 -$14,857,339 +$3,977,264 ENSG, CELH, SMID, TTP, USAC 13F-HR 09 Nov 2022, 13:33
Q2 2022 182 $233,507,000 +$14,053,299 -$13,621,669 +$431,630 ENSG, IIVI, USPH, CELH, CSV 13F-HR 11 Aug 2022, 11:15
Q1 2022 185 $283,420,000 +$9,181,117 -$8,216,528 +$964,589 ENSG, IIVI, CSV, USPH, TTP 13F-HR 11 May 2022, 10:10
Q4 2021 181 $302,195,000 +$9,759,047 -$6,575,855 +$3,183,192 SMID, ENSG, IIVI, CSV, CELH 13F-HR 14 Feb 2022, 11:45
Q3 2021 176 $296,109,000 +$22,754,441 -$15,798,478 +$6,955,963 ENSG, IIVI, CELH, USPH, JYNT 13F-HR 12 Nov 2021, 09:52
Q2 2021 174 $305,573,000 +$29,634,561 -$19,152,776 +$10,481,785 ENSG, IIVI, USPH, JYNT, OSS 13F-HR 12 Aug 2021, 11:15
Q1 2021 158 $276,880,000 +$10,909,195 -$16,053,827 -$5,144,632 ENSG, CELH, IIVI, OSS, WLDN 13F-HR 13 May 2021, 11:24
Q4 2020 152 $253,378,000 +$18,593,961 -$16,465,817 +$2,128,144 CELH, IIVI, ENSG, WLDN, BEEM 13F-HR 11 Feb 2021, 10:54
Q3 2020 153 $188,620,000 +$11,912,238 -$14,158,909 -$2,246,671 CELH, ENSG, IIVI, WLDN, USPH 13F-HR 12 Nov 2020, 12:00
Q2 2020 154 $179,051,000 +$12,599,570 -$8,738,969 +$3,860,601 IIVI, WLDN, USPH, ENSG, CELH 13F-HR 13 Aug 2020, 11:49
Q1 2020 157 $132,276,000 +$3,791,609 -$5,848,795 -$2,057,186 IIVI, WLDN, ENSG, PCYO, USPH 13F-HR 13 May 2020, 11:55
Q4 2019 164 $194,325,000 +$7,532,418 -$10,011,682 -$2,479,264 USPH, WLDN, IIVI, ENSG, PCYO Restatement 13 Feb 2020, 12:29
Q3 2019 166 $195,108,000 +$13,165,678 -$11,546,859 +$1,618,819 USPH, WLDN, IIVI, ENSG, ECC 13F-HR 14 Nov 2019, 12:32
Q2 2019 162 $198,902,000 +$13,680,253 -$18,224,093 -$4,543,840 USPH, WLDN, ENSG, IIVI, ECC 13F-HR 13 Aug 2019, 16:02
Q1 2019 168 $196,896,000 +$4,616,192 -$8,750,419 -$4,134,227 WLDN, USPH, IIVI, ENSG, KWR 13F-HR 13 May 2019, 13:30
Q4 2018 170 $172,985,000 +$10,214,765 -$17,196,844 -$6,982,079 WLDN, USPH, IIVI, ENSG, KWR 13F-HR 13 Feb 2019, 15:57
Q3 2018 172 $216,837,000 +$7,944,880 -$11,294,766 -$3,349,886 IIVI, USPH, WLDN, ENSG, KWR 13F-HR 14 Nov 2018, 12:06
Q2 2018 177 $215,497,000 +$12,389,199 -$14,842,186 -$2,452,987 IIVI, WLDN, USPH, ENSG, KMG 13F-HR 15 Aug 2018, 10:29
Q1 2018 177 $200,606,000 +$8,303,046 -$10,181,586 -$1,878,540 IIVI, WLDN, USPH, CSV, USAC 13F-HR 14 May 2018, 12:58
Q4 2017 175 $208,499,000 +$6,306,830 -$9,946,840 -$3,640,010 IIVI, USPH, WLDN, USAC, KWR 13F-HR 13 Feb 2018, 13:14
Q3 2017 179 $214,810,000 +$2,791,553 -$9,505,728 -$6,714,175 IIVI, WLDN, EVI, HDSN, USPH 13F-HR 14 Nov 2017, 11:55
Q2 2017 187 $220,489,000 +$10,636,259 -$8,415,333 +$2,220,926 IIVI, WLDN, HDSN, EVI, USPH 13F-HR 10 Aug 2017, 14:57
Q1 2017 183 $215,241,000 +$10,897,940 -$14,811,051 -$3,913,111 IIVI, WLDN, USPH, EVI, ACU 13F-HR 12 May 2017, 16:09
Q4 2016 176 $210,732,000 +$8,297,095 -$11,532,347 -$3,235,252 IIVI, USPH, WLDN, HDSN, CSV 13F-HR 14 Feb 2017, 12:45
Q3 2016 174 $204,867,000 +$7,342,829 -$5,708,629 +$1,634,200 IIVI, USPH, DHXM, USAC, HDSN 13F-HR 14 Nov 2016, 15:17
Q2 2016 173 $188,781,000 +$7,476,247 -$7,204,576 +$271,671 USPH, DHXM, TYL, IIVI, CSV 13F-HR 11 Aug 2016, 13:33
Q1 2016 165 $173,623,000 +$14,600,708 -$7,300,031 +$7,300,677 IIVI, DHXM, SRCL, USPH, CSV 13F-HR 12 May 2016, 16:43
Q4 2015 162 $169,568,000 +$10,259,937 -$12,677,920 -$2,417,983 TYL, DHXM, USPH, IIVI, SRCL 13F-HR 12 Feb 2016, 13:54
Q3 2015 163 $173,711,000 +$7,544,446 -$9,143,973 -$1,599,527 SRCL, TYL, DHXM, CSV, IIVI 13F-HR 12 Nov 2015, 12:52
Q2 2015 171 $201,582,000 +$12,094,264 -$13,327,598 -$1,233,334 DHXM, SRCL, TYL, USPH, IIVI 13F-HR 14 Aug 2015, 10:13
Q1 2015 172 $208,527,000 +$6,450,275 -$20,572,088 -$14,121,813 SRCL, TYL, CSV, IIVI, USPH 13F-HR 15 May 2015, 16:10
Q4 2014 174 $213,943,000 +$11,273,142 -$3,920,594 +$7,352,548 TYL, SRCL, SPA, CSV, BCPC Restatement 13 Feb 2015, 14:22
Q3 2014 170 $213,698,000 +$43,803,187 -$72,499,491 -$28,696,304 TYL, SRCL, TPLMQ, EPM, SPA 13F-HR 13 Nov 2014, 15:05
Q2 2014 188 $252,776,000 +$15,326,774 -$9,188,380 +$6,138,394 DHXMF, TYL, SRCL, EPM, TPLMQ 13F-HR 12 Aug 2014, 13:55
Q1 2014 183 $236,477,000 +$3,651,477 -$8,715,226 -$5,063,749 EPM, TYL, SRCL, SPA, DHXMF 13F-HR 09 May 2014, 11:59
Q4 2013 181 $240,398,000 $0 $0 $0 TYL, EPM, DHXMF, SRCL, SPA 13F-HR 12 Feb 2014, 15:51